Skip to main content
Top
Published in: Cancer Causes & Control 3/2015

01-03-2015 | Original Paper

Smoking as an independent determinant of Barrett’s esophagus and, to a lesser degree, of reflux esophagitis

Authors: Rosa Filiberti, Vincenzo Fontana, Antonella De Ceglie, Sabrina Blanchi, Enzo Grossi, Domenico Della Casa, Teresa Lacchin, Marina De Matthaeis, Orazio Ignomirelli, Roberta Cappiello, Monica Foti, Francesco Laterza, Vito Annese, Gaetano Iaquinto, Massimo Conio

Published in: Cancer Causes & Control | Issue 3/2015

Login to get access

Abstract

Purpose

To evaluate the role of smoking in Barrett’s esophagus (BE) and erosive esophagitis (E) compared to endoscopic controls with no BE or E. Smoking is considered a cause of both BE and E, but results on this topic are quite controversial.

Methods

Patients with BE (339), E (462) and controls (619: 280 with GERD (gastroesophageal reflux disease)-negative and 339 with GERD-positive anamnesis) were recruited in 12 Italian endoscopy units. Data were obtained from structured questionnaires.

Results

Among former smokers, a remarkable upward linear trend was found in BE for all smoking-related predictors. In particular, having smoked for more than 32 years increased the risk more than two times (OR 2.44, 95 % CL 1.33–4.45). When the analysis was performed in the subgroup of subjects with GERD-negative anamnesis, the risk of late quitters (<9 years) passed from OR 2.11 (95 % CL 1.19–3.72) to OR 4.42 (95 % CL 1.52–12.8). A noticeably positive dose–response relationship with duration was seen also among current smokers. As regards E, no straightforward evidence of association was detected, but for an increased risk of late quitters (OR 1.84, 95 % CL 1.14–2.98) in former smokers and for early age at starting (OR 3.63, 95 % CL 1.19–11.1) in GERD-negative current smokers.

Conclusions

Smoking seems to be an independent determinant of BE and, to a lesser degree, of E. The elevation in risk is independent from GERD and is already present in light cigarette smokers. Smoking cessation may reduce, but not remove this risk.
Literature
1.
go back to reference Wang KK, Sampliner RE (2008) Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 103:788–797CrossRefPubMed Wang KK, Sampliner RE (2008) Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 103:788–797CrossRefPubMed
2.
go back to reference Ruigomez A, Garcıa Rodrıguez LA, Wallander MA, Johansson S, Dent J (2008) Endoscopic assessment patterns in a cohort of newly diagnosed GERD patients registered in a primary care database. Dis Esophagus 20:504–509CrossRef Ruigomez A, Garcıa Rodrıguez LA, Wallander MA, Johansson S, Dent J (2008) Endoscopic assessment patterns in a cohort of newly diagnosed GERD patients registered in a primary care database. Dis Esophagus 20:504–509CrossRef
3.
go back to reference Kroep S, Lansdorp-Vogelaar I, Rubenstein JH et al (2014) Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands. Am J Gastroenterol 109:336–343CrossRefPubMed Kroep S, Lansdorp-Vogelaar I, Rubenstein JH et al (2014) Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands. Am J Gastroenterol 109:336–343CrossRefPubMed
4.
5.
go back to reference Ronkainen J, Aro P, Storskrubb T et al (2005) Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology 129:1825–1831CrossRefPubMed Ronkainen J, Aro P, Storskrubb T et al (2005) Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology 129:1825–1831CrossRefPubMed
6.
go back to reference Johansson J, Hakansson HO, Mellblom L et al (2007) Risk factors for Barrett’s oesophagus: a population-based approach. Scand J Gastroenterol 42:148–156CrossRefPubMed Johansson J, Hakansson HO, Mellblom L et al (2007) Risk factors for Barrett’s oesophagus: a population-based approach. Scand J Gastroenterol 42:148–156CrossRefPubMed
7.
go back to reference Smith KJ, O’Brien SM, Green AC, Webb PM, Whiteman DC (2009) Current and past smoking significantly increase risk for Barrett’s esophagus. Clin Gastroenterol Hepatol 7:840–848CrossRefPubMed Smith KJ, O’Brien SM, Green AC, Webb PM, Whiteman DC (2009) Current and past smoking significantly increase risk for Barrett’s esophagus. Clin Gastroenterol Hepatol 7:840–848CrossRefPubMed
8.
go back to reference Edelstein ZR, Bronner MP, Rosen SN, Vaughan TL (2009) Risk factors for Barrett’s esophagus among patients with gastroesophageal reflux disease: a community clinic-based case–control study. Am J Gastroenterol 104:834–842CrossRefPubMedCentralPubMed Edelstein ZR, Bronner MP, Rosen SN, Vaughan TL (2009) Risk factors for Barrett’s esophagus among patients with gastroesophageal reflux disease: a community clinic-based case–control study. Am J Gastroenterol 104:834–842CrossRefPubMedCentralPubMed
9.
go back to reference Avidan B, Sonnenberg A, Schnell TG, Sontag SJ (2002) Hiatal hernia and acid reflux frequency predict presence and length of Barrett’s esophagus. Dig Dis Sci 47:256–264CrossRefPubMed Avidan B, Sonnenberg A, Schnell TG, Sontag SJ (2002) Hiatal hernia and acid reflux frequency predict presence and length of Barrett’s esophagus. Dig Dis Sci 47:256–264CrossRefPubMed
10.
go back to reference Anderson LA, Watson RG, Murphy SJ et al (2007) Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol 13:1585–1594CrossRefPubMedCentralPubMed Anderson LA, Watson RG, Murphy SJ et al (2007) Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol 13:1585–1594CrossRefPubMedCentralPubMed
12.
go back to reference Thrift AP, Kramer JR, Richardson PA, El-Serag HB (2014) No significant effects of smoking or alcohol consumption on risk of Barrett’s esophagus. Dig Dis Sci 59:108–116CrossRefPubMedCentralPubMed Thrift AP, Kramer JR, Richardson PA, El-Serag HB (2014) No significant effects of smoking or alcohol consumption on risk of Barrett’s esophagus. Dig Dis Sci 59:108–116CrossRefPubMedCentralPubMed
13.
go back to reference Yates M, Cheong E, Luben R et al (2014) Body mass index, smoking, and alcohol and risks of Barrett’s esophagus and esophageal adenocarcinoma: a UK prospective cohort study. Dig Dis Sci 59:1552–1559CrossRefPubMedCentralPubMed Yates M, Cheong E, Luben R et al (2014) Body mass index, smoking, and alcohol and risks of Barrett’s esophagus and esophageal adenocarcinoma: a UK prospective cohort study. Dig Dis Sci 59:1552–1559CrossRefPubMedCentralPubMed
14.
go back to reference Cook MB, Shaheen NJ, Anderson LA et al (2012) Cigarette smoking increases risk of Barrett’s esophagus: an analysis of the Barrett’s and esophageal adenocarcinoma consortium. Gastroenterology 142:744–753CrossRefPubMedCentralPubMed Cook MB, Shaheen NJ, Anderson LA et al (2012) Cigarette smoking increases risk of Barrett’s esophagus: an analysis of the Barrett’s and esophageal adenocarcinoma consortium. Gastroenterology 142:744–753CrossRefPubMedCentralPubMed
15.
go back to reference Lee D, Lee KJ, Kim KM, Lim SK (2013) Prevalence of asymptomatic erosive esophagitis and factors associated with symptom presentation of erosive esophagitis. Scand J Gastroenterol 48:906–912CrossRefPubMed Lee D, Lee KJ, Kim KM, Lim SK (2013) Prevalence of asymptomatic erosive esophagitis and factors associated with symptom presentation of erosive esophagitis. Scand J Gastroenterol 48:906–912CrossRefPubMed
16.
go back to reference Jonaitis L, Kriukas D, Kiudelis G, Kupčinskas L (2011) Risk factors for erosive esophagitis and Barrett’s esophagus in a high Helicobacter pylori prevalence area. Medicina (Kaunas) 47:434–439 Jonaitis L, Kriukas D, Kiudelis G, Kupčinskas L (2011) Risk factors for erosive esophagitis and Barrett’s esophagus in a high Helicobacter pylori prevalence area. Medicina (Kaunas) 47:434–439
17.
go back to reference Sharma P, McQuaid K, Dent J et al (2004) A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop. Gastroenterology 127:310–330CrossRefPubMed Sharma P, McQuaid K, Dent J et al (2004) A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop. Gastroenterology 127:310–330CrossRefPubMed
18.
go back to reference Wang KK, Sampliner RE, Practice Parameters Committee of the American College of Gastroenterology (2008) Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 103:788–797CrossRefPubMed Wang KK, Sampliner RE, Practice Parameters Committee of the American College of Gastroenterology (2008) Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 103:788–797CrossRefPubMed
19.
go back to reference Sharma P, Dent J, Armstrong D et al (2006) The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 131:1392–1399CrossRefPubMed Sharma P, Dent J, Armstrong D et al (2006) The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 131:1392–1399CrossRefPubMed
20.
go back to reference Levine DS, Haggitt RC, Blount PL et al (1993) An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology 105:40–50PubMed Levine DS, Haggitt RC, Blount PL et al (1993) An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology 105:40–50PubMed
21.
go back to reference Reid BJ, Blount PL, Feng Z et al (2000) Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. Am J Gastroenterol 95:3089–3096CrossRefPubMed Reid BJ, Blount PL, Feng Z et al (2000) Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. Am J Gastroenterol 95:3089–3096CrossRefPubMed
22.
go back to reference Lundell LR, Dent J, Bennett JR et al (1999) Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45:172–180CrossRefPubMedCentralPubMed Lundell LR, Dent J, Bennett JR et al (1999) Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45:172–180CrossRefPubMedCentralPubMed
23.
go back to reference Anand G, Katz PO (2010) Gastroesophageal reflux disease and obesity. Rev Gastroenterol Clin North Am 39:39–46CrossRef Anand G, Katz PO (2010) Gastroesophageal reflux disease and obesity. Rev Gastroenterol Clin North Am 39:39–46CrossRef
24.
go back to reference Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley, USACrossRef Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley, USACrossRef
25.
go back to reference Leffondré K, Abrahamowicz M, Siemiatycki J, Rachet B (2002) Modeling smoking history: a comparison of different approaches. Am J Epidemiol 156:813–823CrossRefPubMed Leffondré K, Abrahamowicz M, Siemiatycki J, Rachet B (2002) Modeling smoking history: a comparison of different approaches. Am J Epidemiol 156:813–823CrossRefPubMed
26.
go back to reference Neuner B, Wellmann J, Dasch B et al (2007) Modeling smoking history: a comparison of different approaches in the MARS study on age-related maculopathy. Ann Epidemiol 17:615–621CrossRefPubMed Neuner B, Wellmann J, Dasch B et al (2007) Modeling smoking history: a comparison of different approaches in the MARS study on age-related maculopathy. Ann Epidemiol 17:615–621CrossRefPubMed
28.
go back to reference Koek GH, Sifrim D, Lerut T, Janssens J, Tack J (2008) Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett’s oesophagus. Gut 57:1056–1064CrossRefPubMed Koek GH, Sifrim D, Lerut T, Janssens J, Tack J (2008) Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett’s oesophagus. Gut 57:1056–1064CrossRefPubMed
29.
go back to reference El-Serag H, Hill C, Jones R (2008) Systematic review: the epidemiology of gastro-esophageal reflux disease in primary care, using the UK general practice database. Aliment Pharmacol Ther 29:470–480CrossRefPubMed El-Serag H, Hill C, Jones R (2008) Systematic review: the epidemiology of gastro-esophageal reflux disease in primary care, using the UK general practice database. Aliment Pharmacol Ther 29:470–480CrossRefPubMed
30.
go back to reference Ronkainen J, Aro P, Storskrubb T et al (2005) High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 40:275–285CrossRefPubMed Ronkainen J, Aro P, Storskrubb T et al (2005) High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 40:275–285CrossRefPubMed
31.
go back to reference El-Serag HB (2006) Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 5:17–26CrossRefPubMed El-Serag HB (2006) Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 5:17–26CrossRefPubMed
32.
go back to reference Vaughan TL, Davis S, Kristal A, Thomas DB (1995) Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 4:85–92PubMed Vaughan TL, Davis S, Kristal A, Thomas DB (1995) Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 4:85–92PubMed
33.
go back to reference Freedman ND, Abnet CC, Leitzmann MF et al (2007) A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 165:1424–1433CrossRefPubMed Freedman ND, Abnet CC, Leitzmann MF et al (2007) A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 165:1424–1433CrossRefPubMed
34.
go back to reference Conio M, Filiberti R, Blanchi S et al (2002) Risk factors for Barrett’s esophagus: a case–control study. Int J Cancer 97:225–229CrossRefPubMed Conio M, Filiberti R, Blanchi S et al (2002) Risk factors for Barrett’s esophagus: a case–control study. Int J Cancer 97:225–229CrossRefPubMed
36.
go back to reference Steevens J, Schouten LJ, Driessen AL et al (2011) A prospective cohort study on overweight, smoking, alcohol consumption, and risk of Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 20:345–358CrossRefPubMed Steevens J, Schouten LJ, Driessen AL et al (2011) A prospective cohort study on overweight, smoking, alcohol consumption, and risk of Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 20:345–358CrossRefPubMed
37.
go back to reference Ruigomez A, Garcıa Rodrıguez LA, Wallander MA, Johansson S, Graffner H, Dent J (2004) Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 20:751–760CrossRefPubMed Ruigomez A, Garcıa Rodrıguez LA, Wallander MA, Johansson S, Graffner H, Dent J (2004) Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 20:751–760CrossRefPubMed
38.
go back to reference Eloubeidi MA, Provenzale D (2001) Clinical and demographic predictors of Barrett’s esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. J Clin Gastroenterol 33:306–309CrossRefPubMed Eloubeidi MA, Provenzale D (2001) Clinical and demographic predictors of Barrett’s esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. J Clin Gastroenterol 33:306–309CrossRefPubMed
39.
40.
go back to reference Knoke JD, Burns DM, Thun MJ (2008) The change in excess risk of lung cancer attributable to smoking following smoking cessation: an examination of different analytic approaches using CPS-I data. Cancer Causes Control 19:207–219CrossRefPubMed Knoke JD, Burns DM, Thun MJ (2008) The change in excess risk of lung cancer attributable to smoking following smoking cessation: an examination of different analytic approaches using CPS-I data. Cancer Causes Control 19:207–219CrossRefPubMed
41.
go back to reference Namiot DB, Leszczynska K, Namiot Z, Kurylonek AJ, Kemona A (2008) Smoking and drinking habits are important predictors of Helicobacter pylori eradication. Adv Med Sci 53:310–315CrossRefPubMed Namiot DB, Leszczynska K, Namiot Z, Kurylonek AJ, Kemona A (2008) Smoking and drinking habits are important predictors of Helicobacter pylori eradication. Adv Med Sci 53:310–315CrossRefPubMed
42.
go back to reference Corley DA, Kubo A, Levin TR et al (2008) Helicobacter pylori infection and the risk of Barrett’s oesophagus: a community-based study. Gut 57:727–733CrossRefPubMedCentralPubMed Corley DA, Kubo A, Levin TR et al (2008) Helicobacter pylori infection and the risk of Barrett’s oesophagus: a community-based study. Gut 57:727–733CrossRefPubMedCentralPubMed
43.
go back to reference Andrici J, Cox MR, Eslick GD (2013) Cigarette smoking and the risk of Barrett’s esophagus: a systematic review and meta-analysis. J Gastroenterol Hepatol 28:1258–1273CrossRefPubMed Andrici J, Cox MR, Eslick GD (2013) Cigarette smoking and the risk of Barrett’s esophagus: a systematic review and meta-analysis. J Gastroenterol Hepatol 28:1258–1273CrossRefPubMed
44.
go back to reference El-Serag HB, Petersen NJ, Carter J et al (2004) Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 126:1692–1699CrossRefPubMed El-Serag HB, Petersen NJ, Carter J et al (2004) Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 126:1692–1699CrossRefPubMed
45.
go back to reference Nandurkar S, Locke GR III, Murray JA et al (2005) Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol 100:1459–1465CrossRefPubMed Nandurkar S, Locke GR III, Murray JA et al (2005) Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol 100:1459–1465CrossRefPubMed
46.
go back to reference Smith KJ, O’Brien SM, Smithers BM et al (2005) Interactions among smoking, obesity, and symptoms of acid reflux in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 14:2481–2486CrossRefPubMedCentralPubMed Smith KJ, O’Brien SM, Smithers BM et al (2005) Interactions among smoking, obesity, and symptoms of acid reflux in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 14:2481–2486CrossRefPubMedCentralPubMed
47.
go back to reference Labenz J, Jaspersen D, Kulig M et al (2004) Risk factors for erosive esophagitis: a multivariate analysis based on theProGERD study initiative. Am J Gastroenterol 99:1652–1656CrossRefPubMed Labenz J, Jaspersen D, Kulig M et al (2004) Risk factors for erosive esophagitis: a multivariate analysis based on theProGERD study initiative. Am J Gastroenterol 99:1652–1656CrossRefPubMed
48.
go back to reference Avidan B, Sonnenberg A, Schnell T, Sontag S (2001) Risk factors for erosive reflux esophagitis: a case–control study. Am J Gastroenterol 96:41–46CrossRefPubMed Avidan B, Sonnenberg A, Schnell T, Sontag S (2001) Risk factors for erosive reflux esophagitis: a case–control study. Am J Gastroenterol 96:41–46CrossRefPubMed
Metadata
Title
Smoking as an independent determinant of Barrett’s esophagus and, to a lesser degree, of reflux esophagitis
Authors
Rosa Filiberti
Vincenzo Fontana
Antonella De Ceglie
Sabrina Blanchi
Enzo Grossi
Domenico Della Casa
Teresa Lacchin
Marina De Matthaeis
Orazio Ignomirelli
Roberta Cappiello
Monica Foti
Francesco Laterza
Vito Annese
Gaetano Iaquinto
Massimo Conio
Publication date
01-03-2015
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 3/2015
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0518-8

Other articles of this Issue 3/2015

Cancer Causes & Control 3/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine